Cary Street Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
592
-4
-0.7% -$1.69K 0.01% 881
2026
Q1
$282K Buy
596
+6
+1% +$3.02K 0.01% 730
2025
Q4
$276K Hold
590
0.01% 750
2025
Q3
$251K Buy
590
+22
+4% +$8.53K 0.01% 728
2025
Q2
$217K Buy
568
+7
+1% +$2.52K 0.01% 744
2025
Q1
$194K Sell
561
-62
-10% -$19.9K 0.01% 754
2024
Q4
$187K Buy
+623
New +$218K 0.01% 734

Other funds holding HCA

Cary Street Partners's HCA Position: Q2 2026 in Review

Cary Street Partners reduced its HCA Healthcare (HCA) stake by 0.67% in Q2 2026, selling an estimated $1.69K and leaving 592 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #881.

Cary Street Partners first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $282K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Cary Street Partners held 592 shares of HCA Healthcare worth $231K as of Q2 2026.
  • Cary Street Partners sold 4 HCA Healthcare shares in Q2 2026, an estimated $1.69K.
  • HCA Healthcare made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #881 holding.
  • Cary Street Partners first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's HCA Healthcare position peaked at $282K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.